![Michael Kring](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Kring
Chief Executive Officer at High Tech Corporate Services GmbH
Network origin in Michael Kring first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Biotechnology | 3 | |
High Tech Corporate Services GmbH
![]() High Tech Corporate Services GmbH Miscellaneous Commercial ServicesCommercial Services High Tech Corporate Services GmbH provides business development and management support services. The firm specializes in the establishment, structuring, and management of administrative and financial divisions of start-up and existing companies. Its service areas encompass administrative and project management, corporate finance, corporate planning and controlling, and human resources. It also provides support during financing rounds, with focus on technology segments of various industries and services. The company was founded by Michael Kring in September 2005 and is headquartered in Munich, Germany.
3
| Private Company | Miscellaneous Commercial Services | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Michael Kring via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Wyeth Corp.
![]() Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
AGENUS INC. | Biotechnology | Corporate Officer/Principal | |
Sandoz, Inc.
![]() Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Director of Finance/CFO | |
NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of Washington
![]() University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Doctorate Degree | |
EVOTEC SE | Pharmaceuticals: Major | Corporate Officer/Principal | |
Rice University | College/University | Undergraduate Degree | |
NextPharma Technologies Ltd.
![]() NextPharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology NextPharma Technologies, In. develops, manufactures, packages, and distributes pharmaceutical products and formulations. The firm focuses on lyophilization, sterile fill finish and pellet technologies, and in product manufacturing including cyotoxics, hormones, penicillins, cephalosporins, and controlled drugs. The company was established on October 27, 2000 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Massachusetts Institute of Technology | College/University | Doctorate Degree | |
University of Arizona | College/University | Graduate Degree | |
Ludwig-Maximilians-Universität München | College/University | Doctorate Degree | |
King's College London | College/University | Undergraduate Degree | |
KWS BioTest Ltd.
![]() KWS BioTest Ltd. Pharmaceuticals: MajorHealth Technology KWS BioTest Ltd. provides preclinical pharmacology and drug development for human diseases. Its capabilities include clinical biomarkers, cell biology, bioanalytical services, in vivo pharmacology, vaccine development. The company was founded by Williams A. Neil and Trevor Langley in 2004 and is headquartered in Bristol, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
JPT Peptide Technologies GmbH
![]() JPT Peptide Technologies GmbH Medical SpecialtiesHealth Technology JPT Peptide Technologies GmbH provides innovative peptide based products and services for vaccine development, immune monitoring and peptide biomarker discovery. The firm’s products include custom peptides, modified & labeled peptides, clinical peptides, stable isotope-labeled peptides, SPOT peptides, immunogenic peptides, peptide libraries, peptide pools, peptide microarrays, peptide ELISA, enzyme profiling and epitope discovery service. The company was founded in 2004 and is headquartered in Berlin, Germany. | Medical Specialties | Chief Executive Officer Chief Executive Officer | |
BioNTech Diagnostics GmbH
![]() BioNTech Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of BioNTech SE, BioNTech Diagnostics GmbH is a German company that researches and develops peptide synthesis solutions. The company is based in Mainz, Germany. The company was founded in 2009. The CEO is Sierk Poetting. | Miscellaneous Commercial Services | Chief Executive Officer | |
Encompass Northwest
![]() Encompass Northwest Services to the Health IndustryHealth Services Encompass Northwest is a non-profit organization, which provides education and pediatric therapy programs to typically-developing children and those with delays and/or disabilities. It offers early learning, parent education, parent-child interaction therapy, and family enrichment programs. The company was founded in 1966 and is headquartered in North Bend, WA. | Services to the Health Industry | Director/Board Member | |
Manchester Business School | College/University | Masters Business Admin | |
UCB Celltech
![]() UCB Celltech BiotechnologyHealth Technology Part of UCB SA, UCB Celltech is a British company that develops novel therapeutic products for humans. The company is based in Slough, UK and was founded in 2006. | Biotechnology | Corporate Officer/Principal | |
Cadence Biomedical, Inc.
![]() Cadence Biomedical, Inc. Medical DistributorsDistribution Services Cadence Biomedical, Inc. provides medical devices for mobility impairments. Its product kickstart is a neurorehabilitation technology used to train walking skills and enable more independent, safe walking for patients following a stroke or other neurological condition. The company was founded by Jason A. Schoen and Brian Glaister in August 2007 and is headquartered in Seattle, WA. | Medical Distributors | Director/Board Member | |
Harvard Business School | College/University | Masters Business Admin | |
Mann Bioinvest Ltd.
![]() Mann Bioinvest Ltd. Financial ConglomeratesFinance Mann Bioinvest Ltd. invests in the life science sector. The company was founded by James Mellon in 2012 and is headquartered in Douglas, the United Kingdom. | Financial Conglomerates | Director/Board Member | |
BioNTech Small Molecules GmbH
![]() BioNTech Small Molecules GmbH BiotechnologyHealth Technology BioNTech Small Molecules GmbH engages in the research and development of synthetic compounds against cancer and other diseases. The company was founded on April 11, 2016 and is headquartered in Mainz, Germany. | Biotechnology | Chief Executive Officer | |
Achilles Therapeutics UK Ltd.
![]() Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Aicuris Anti-Infective Cures AG
![]() Aicuris Anti-Infective Cures AG Miscellaneous Commercial ServicesCommercial Services Part of Santo Holding (Deutschland) GmbH, Aicuris Anti-Infective Cures AG aims to discover, develop, and deliver innovative, anti-viral drugs to immunocompromised patients aiming to prevent severe condition and life-threatening diseases. The company is based in Wuppertal, Germany. Aicuris has developed a commercial drug as well as pipeline of clinical-stage and pre-clinical anti-viral candidates. Its lead product Prevymis® (letermovir), a first-in-class non-nucleoside cytomegalovirus (CMV) inhibitor, was licensed to MSD and is commercialized for the prevention of human CMV infections in immunocompromised patients who underwent an allogeneic hematopoietic stem cell transplantation or kidney transplantation. Aicuris wholly owned product candidate, Pritelivir, targeting resistant herpes simplex virus (HSV) infections in immunocompromised patients, is in phase 3 clinical development. The German company was founded in 2006 by Helga Rübsamen-Schaeff. Larry G. Edwards has been the CEO of the company since 2023. | Miscellaneous Commercial Services | Director/Board Member | |
IQM Finland Oy
![]() IQM Finland Oy Information Technology ServicesTechnology Services IQM Finland Oy operates as a quantum computing company. It engages in building hardware for quantum computers that focuses on superconducting technology. The company was founded by Juha Johannes Vartiainen, Kuan Yen Tan, Jan Goetz, and Mikko Pentti Matias M?tt?nen and is headquartered in Espoo, Finland. | Information Technology Services | Chairman | |
PHMR Ltd.
![]() PHMR Ltd. Information Technology ServicesTechnology Services Part of UDG Healthcare Ltd. (Dublin), PHMR Ltd. is a healthcare consulting British company that specializes in insight-enabled pricing and market access approaches to ensure successful product launch and life-cycle management. The company is based in London, UK. The company helps its clients in the healthcare industries build value for their products by using academically-proven analytical methods to find and form clinical, economic, and humanistic evidence. PHMR is an international team of highly qualified health economists and research scientists. The company was founded by Mark Ratcliffe, who has been the CEO since incorporation. PHMR was acquired by UDG Healthcare Ltd. (Dublin) on January 26, 2021 for $43.75 million. | Information Technology Services | Chairman | |
BioNTech Delivery Technologies GmbH
![]() BioNTech Delivery Technologies GmbH Miscellaneous Commercial ServicesCommercial Services Part of BioNTech SE, BioNTech Delivery Technologies GmbH is a German company that engages in research and development of immunotherapies. The company is based in Halle, Germany. The CEOs of the company are Ugur Sahin, Sierk Poetting. | Miscellaneous Commercial Services | Chief Executive Officer | |
MONTE ROSA THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
McKinsey GmbH & Co. KG
![]() McKinsey GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services McKinsey GmbH & Co. KG provides business consulting services. The company was founded on October 18, 2011 and is headquartered in Düsseldorf, Germany. | Miscellaneous Commercial Services | Corporate Officer/Principal |
Statistics
International
United States | 14 |
United Kingdom | 11 |
Germany | 9 |
Switzerland | 2 |
Finland | 2 |
Sectoral
Health Technology | 17 |
Consumer Services | 8 |
Commercial Services | 5 |
Finance | 3 |
Technology Services | 3 |
Operational
Corporate Officer/Principal | 14 |
Director/Board Member | 6 |
Chief Executive Officer | 6 |
Undergraduate Degree | 3 |
Doctorate Degree | 3 |
Most connected contacts
Insiders | |
---|---|
Sean Marett | 15 |
John Castle | 11 |
Sierk Poetting | 11 |
Ralf Schmidt | 1 |
Sabine Klepp | 1 |
Roman Austermayer | 1 |
- Stock Market
- Insiders
- Michael Kring
- Company connections